Savings Experiment: Snow Removal
The Money Man Behind Rick Santorum: Who Is Foster S. Friess?
The markets were very mixed going into the close and which direction the closing bell was going to be was not known until right at the close. Core consumer inflation seems to still be contained, although oil rose sharply today on supply and refining concerns. Even the FOMC decision to keep rates at the near-zero policy and keeping the "extended time" phrase on for extremely low fed funds rates did not hurt the markets today. Here were today's unofficial closing bell levels:
Dow 10,441.12 -10.88 (-0.10%)
S&P 500 1,109.18 +1.25 (0.11%)
Nasdaq 2,206.91 +5.86 (0.27%)
Top Analyst Calls
Top Day Trader Alerts
Team Health (TMH) managed to sit above its price of $12.00 all day, but at $12.85 late in the session there are reasons this one deserves poor marks for a IPO grade.
Achillion Pharmaceuticals (ACHN) was the next chased biotech stock based on positive study data on Hepatits C. Shares were up 51% at $3.24 late in the trading day.
Intel Corporation (INTC) fell after an FTC lawsuit alleged that the processor and chip behemoth stifled competition and strengthened its own dominant position and market share for microchips. This had shares down 2.5% at $19.30 late in the day. The winners on this were Advanced Micro Devices (AMD) up almost 4% and NVIDIA Corporation (NVDA) up almost 8% ahead of today's closing bell.
Fannie Mae (FNM) was down 8.5% at $1.08 late in the trading after it conducted a 5-year benchmark note sale. Step-brother Freddie Mac (FRE) was also down 8.8% at $1.35 late in the day.
Delta Petroleum (DPTR) made it a third day in the rally with shares up 17.9% at $1.25 on major volume as traders are chasing speculative energy names.
Playboy Enterprises, Inc. (PLA) recovered from lows, but shares were still down 9.9% at $3.46 before the close on reports that a buyer of Heff's adult magazine empire walked away from the table.
Goldman Earnings Sink After Buffett Dividend
Johnson & Johnson's Income Falls 23%
Burberry Shares Leap on Sales Update
